BLACK DIAMOND THERAPEUTICS, INC. (BDTX)
Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
F&G Annuities & Life Declares Dividends on Common and Preferred Stock
Cheniere Reports First Quarter 2026 Results and Raises Full Year 2026 Financial Guidance
Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic
Harvard Bioscience to Participate in Upcoming Investor Conferences
Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Soluna Announces Monthly Business Update
Ascendis Pharma Reports First Quarter 2026 Financial Results
Evaxion announces business update and first quarter 2026 financial results
QuasarEdge Acquisition Corporation Signs Letter of Intent to Acquire Robseek Intelligence Inc.